IMVIONIX ACQUIRES U.S. AND CANADIAN RIGHTS TO BEOVU® (BROLUCIZUMAB-DBLL), MARKING THE COMPANY'S OFFICIAL LAUNCH

Reuters · 6d ago

Please log in to view news